Medtech deal-making stands firm in difficult times
It takes more than a pandemic to stop medical device companies merging.
Thermo Fisher and the new variant
Pinpointing new forms of the coronavirus could be vital, particularly if it mutates in response to vaccination, the company says.
A tale of two Covids for smaller device makers
The pandemic provided the best and worst of times for smid-cap medtechs.
